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Background: Emergency department (ED) utilization by children with cancer is poorly understood. 
Among children with cancer, we explored reasons for ED visits and factors associated with admission 
within U.S. children’s hospitals.  
 
Methods: A retrospective study of the 2011-2013 Pediatric Health Information System (PHIS) was 
conducted. Eligible ED visits included those within 365 days from the first inpatient encounter with 
 
Admit Peds Ca  
 
This article is protected by copyright. All rights reserved. 
 
3 
an ICD-9-CM code for cancer. Patient characteristics and reasons for ED visits were assessed. Factors 
associated with admission from the ED were examined with multivariable regression. 
 
Results: There were 26,770 ED visits by 17,943 children with cancer at 39 children’s hospitals during 
the study period. Half of children with cancer visited the ED within one year after their first cancer 
hospitalization in PHIS. Fifty-six percent of ED visits resulted in admission. Fever or neutropenia 
accounted for the largest proportion of reasons for visits (34.6%). Risk factors for admission were: 
“Other” race/ethnicity as compared to white, non-Hispanic (OR=1.4, 95% CI 1.2-1.6), history of 
transplant (OR=1.7, 95% CI 1.4-2.1), and ED visits reasons including neutropenia (OR=43.4, 95% CI 
36.0-52.3), blood stream infection (OR=3.3, 95% CI 2.8-3.9), pancytopenia (OR=28.8, 95% CI 18.1-
45.9), dehydration (OR=2.3, 95% CI 1.9-2.9) or pneumonia (OR=3.8, 95% CI 2.8-5.1).  
 
Conclusion: Children with cancer have high ED usage within one year after their first cancer 
hospitalization. Age, demographic factors and reasons for ED visits significantly impacted admission 
from the ED. Further research should focus on ED utilization among children with cancer.  
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Children with cancer represent a high-risk population for disease and treatment related 
complications that require urgent or emergent medical care.[1-4] These children are frequently 
referred to emergency departments (ED) for evaluation of high risk, time-sensitive conditions such as 
febrile neutropenia (FN) and sepsis.  
Improved understanding of the ED utilization of children with cancer could lead to 
optimization of ED referral practices and ED management through targeted interventions aimed at the 
most common reasons for ED visits and admissions. While admission rates for children with cancer 
vary by reason for the ED visit,[5] the role of patient level factors on the decision to hospitalize are 
poorly defined. 
 The objectives of this study were to (a) assess ED utilization by pediatric patients with cancer 
and evaluate the reasons why children with cancer visit the ED, and (b) assess factors associated with 
admission versus discharge from the ED at children’s hospitals in the United States, including patient 
specific factors unavailable in previously analyzed datasets.  
 
Methods 
Study Design and Setting 
We conducted a retrospective cohort study using data from the Pediatric Health Information 
System (PHIS), an administrative and resource utilization database from 45 freestanding children’s 
hospitals. Participating hospitals are located in non-competing markets of 27 states plus the District of 
Columbia and account for ~15% of all pediatric hospitalizations in the United States. Hospitals were 
included if they provided inpatient and ED data between January 1, 2011, and September 30, 2013, 
without interruption, resulting in the inclusion of 39 hospitals. The PHIS database contains the 
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following: patient medical record data (demographic characteristics, up to 41 diagnoses, and up to 41 
procedures) and billing data (all medication, diagnostic imaging, laboratory, and supply charges to 
individual patients). Diagnoses are coded after discharge, so we are unable to separate ED versus 
inpatient diagnoses for those patients who were admitted. Data are de-identified before inclusion in 
the database; however, encrypted medical record numbers allow for tracking of individual patients 
across multiple encounters at the same hospital. The Children’s Hospital Association (Overland Park, 
KS) and participating hospitals jointly monitor the quality and integrity of data, described 
previously.[6] The analysis was based on de-identified data and was therefore considered exempt 
from institutional review board approval by Indiana University School of Medicine.  
 
Study Population/Identification of Cases 
Children with cancer were defined based on the identification of an inpatient encounter that 
included an International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-
CM) code for cancer (140.x-209.x, 235.x-239.x), as described previously.[5] The index inpatient 
encounter was defined as the first inpatient encounter with an ICD-9-CM code for cancer in the study 
period only if there were no previous hospitalizations with cancer diagnoses within 365 days prior. 
We then identified all ED visits that occurred in the 365 days following the index hospitalization. We 
restricted our analysis to those patients between the ages of 0-19 years.  
Outcome and Exploratory Variables 
Patient characteristics that were evaluated included: gender, age (<1 year, 1-4 years, 5-9 
years, 10-14 years, 15-19 years – based on clinical differences in types of cancers and development 
differences), race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, Asian, or other), type 
of cancer (acute lymphoblastic leukemia (ALL), acute myelogenous leukemia, central nervous system 
tumors (CNS), solid tumors (non-CNS), Hodgkin lymphoma, and non-Hodgkin lymphoma (NHL)), 
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transplant status flag (defined using Feudtner’s complex chronic condition codes, including stem cell 
transplant)[7], primary payer (public/governmental, private, other), median income quartile per ZIP 
code and urban/rural patient residence (based on the Rural Urban Commuting Area (RUCA) code of 
the patient’s home ZIP code).[8] We also included an indicator variable for frequent ED visitor, which 
was defined as 4 or more visits (greater than the 90
th
 percentile among the study population of 
children with cancer) during the year (365 days) following the index admission.  
For the logistic regression, the primary outcome of interest was whether an ED visit resulted 
in admission to the same institution versus discharged to home (patient treated and released from the 
ED). Deaths occurring in the ED were excluded from this analysis; there were only 7 ED deaths in the 
time period analyzed.  
 
Reason for ED visit 
The reason prompting an ED visit was defined by the primary ICD-9-CM discharge diagnosis 
associated with the encounter, unless the primary diagnosis was a cancer diagnosis (ICD-9-CM Codes 
140-239). In cases where a cancer diagnosis was the primary diagnosis, the second listed ICD-9-CM 
diagnosis was considered to be the reason prompting the ED visit. Cancer diagnoses were not 
considered the reason prompting an ED visit in order to focus on symptoms or complications 
associated with ED visits made by pediatric patients with cancer. A rank list of diagnoses was 
generated by frequency. Diagnoses with similar codes were collapsed into single categories, for 
example “neutropenia, unspecified” (288.00) and “drug induced neutropenia” (288.03) were collapsed 
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Hospital and patient characteristics were summarized using frequencies and percentages, and 
compared across groups (admitted vs. discharged from the ED) using chi-square tests. The number of 
ED visits and corresponding disposition status (admitted or discharged) were analyzed. The top 10 
reasons for ED visits by disposition status (admitted or discharged) were calculated by frequencies 
and proportions. Multivariable regression was performed using generalized linear mixed effects 
models to estimate factors associated with admission for pediatric patients with cancer while 
accounting for clustering of patients within hospitals through the inclusion of a random hospital 
intercept. Variables included were based on our defined model: gender, patient’s age category, type of 
cancer, presence of a transplant flag, primary expected payer, median income quartile per ZIP code, 
urban/rural patient residence, a dichotomous indicator variable for frequent ED visitors, and variables 
for the presence or absence of each of the top 10 most common visit diagnoses. All analyses were 
performed using SAS v9.4 (SAS Institute, Cary, NC), and p-values <0.05 were considered statistically 
significant.   
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Characteristic of the study population 
We identified 17,943 children with cancer who received inpatient care with associated ICD-9-
CM codes for cancer at 39 children’s hospitals in the United States, from January 2011-September 
2013. There were a total of 26,770 ED visits in the year following the index hospitalization among 
9,114 (50.8%) of the identified children with cancer. The range for the number of ED visits per 
patient was 0-24, the distribution as shown in Figure 1. Among all of the ED visits, 56.1% (n=15,022) 
were admitted and 43.9% (n=11,748) were discharged to home; there were no transfers to other 
institutions. 
Table 1 demonstrates the encounter characteristics of children with cancer who presented to 
the ED, stratified by admission versus discharge from the ED. Overall, most ED visits were for 
children ages 0-9 years (65.9%), white, non-Hispanic (53.5%), and residing in urban areas (86.1%). 
There were significant differences between encounters resulting in admission vs. discharge for all 
factors investigated, except for primary payer.  
 The ten most common reasons prompting an ED visit for the children with cancer (Table 2) 
accounted for one half (50.8%) of all non-cancer primary diagnoses for ED visits among children with 
cancer. A diagnosis of fever or neutropenia, common complications of cancer therapy, accounted for 
the largest percentage of visits (34.6%).  
 Variation in ED disposition was found across diagnoses. Children with cancer were admitted 
the majority of the time if their reasons for ED visit was neutropenia (97.5%), pancytopenia (96.4%), 
blood stream infections (75.5%), pneumonia (78.1%), and dehydration (69.6%). The lowest admission 
rates were for principal diagnoses of fever (23.3%), complication of a vascular device (20.0%), and 
headache (20.0%).  
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Factors affecting admission versus discharge among children with cancer 
 In a multivariable analysis, patient factors associated with significantly increased odds of 
admission included “Other” race/ethnicity as compared to white, non-Hispanic (Odds Ratio [OR]=1.4, 
95% Confidence Interval [CI] 1.2-1.6) or having a history of transplant (OR=1.7, 95% CI 1.4-2.1), as 
shown in Table 3. Conversely, all age groups had significantly decreased odds of admission when 
compared with the patient encounters for those ages 15-19 years. Among the cancer diagnoses, none 
of the categories had significantly increased odds of admission when compared to the reference of 
ALL. Meeting criteria for a frequent ED user also did not increase the odds of admission.  
 Patients who lived in urban settings had decreased odds of admission (OR=0.7, 95% CI 0.6-
0.8) compared with those living in a rural residence. 
ED visit diagnoses associated with increased odds of admission included neutropenia 
(OR=43.4, 95% CI 36.0-52.3), blood stream infection (OR=3.3, 95% CI 2.8-3.9), pancytopenia 
(OR=28.8, 95% CI 18.1-45.9), dehydration (OR=2.3, 95% CI 1.9-2.9) or pneumonia (OR=3.8, 95% 
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In this study using administrative data from 39 U.S. children’s hospitals, half of children with cancer 
visited the ED within one year of their index inpatient encounter in the study period. Over half of 
these ED visits resulted in hospital admission, which is a higher rate than the general pediatric 
population (about 10%).[9,10] Consistent with our previous analysis of a nationally representative 
sample of ED visits, we found that there was significant variation in admission rates across the wide 
range of reasons for ED visits in this patient population.[5] Though the variation cannot be fully 
explained using administrative data, we have confirmed that admission rates are highest for those with 
neutropenia and lowest for those with headaches. This analysis highlights two potential areas for 
future intervention. For ED visit reasons that had high admission rates, research endeavors could 
focus understanding the patient experience and improving patient-centered outcomes. Conversely, 
research concentrated on those reasons with low admission rates could aim to improve anticipatory 
guidance given to caregivers to decrease reliance on the ED.  
 Consistent with our prior research, there was a wide range of reasons for ED visits among 
children with cancer.[5] We chose to focus on only the primary diagnosis, or the second diagnosis 
code if the first was a cancer diagnosis, in order to ascertain the reason for the ED visit. Yet, it is 
likely that children with cancer can present to the ED with more than one medical issue. Febrile 
neutropenia (FN) is a clinically important entity, but is not a single diagnostic code. We also found 
similar admission rates between patients with a primary ED visit diagnosis of neutropenia and FN 
(when we identified a combination of fever and neutropenia among all diagnostic fields). To truly 
understand ED utilization for children with cancer who experience fever in the setting of neutropenia, 
datasets will need to include chief complaints and laboratory data.  
 While children with cancer are a small subset of all children who visit the ED (0.2%),[5] there 
are important distinctions regarding the care for this unique population. Counter to ED admission 
patterns for common pediatric conditions, children with cancer who were younger (as compared to the 
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15-19 year olds) had decreased odds of admission. This finding lends itself to future research 
regarding reasons for these differences. Possible explanations include adolescents waiting to visit the 
ED only when they have reached the point where their condition requires inpatient admission or, 
alternatively, young children may be taken to the ED early in the course of an acute illness due to 
their limited ability to explain their symptoms. Also, ALL occurs more commonly in younger children 
and requires the longest duration of active chemotherapy, but the majority of therapy is maintenance 
chemotherapy with low risk for substantial immunosuppression. Further research that includes greater 
patient detail regarding the reason for seeking ED care will be needed to improve our understanding 
of this dynamic.  
 Socioeconomic factors appeared to impact the disposition of children with cancer from the 
ED. Patients who lived in an urban location, had decreased odds of admission, which may be because 
patients who live in urban areas may live closer to the free-standing children’s hospitals that 
contributed to this analysis. Therefore, patients living in closer urban areas are more easily able to 
return for re-evaluation if their condition worsens. Those who live further away, in rural areas, may 
experience hardship related to travel including lack of adequate means of transportation, the cost of 
traveling or lodging nearby. This may result in longer hospital admissions to ensure stability prior to 
discharge or visits to other hospitals with subsequent transfer only if admission is deemed necessary. 
Of note, risk stratification schemas for the management of febrile neutropenia (FN) among children 
with cancer do not take into account the differences in patient proximity to the treating hospital.[11-
13] 
The PHIS database has several unique features that revealed important information in this 
study. First, we had the ability to identify patients with a comorbid condition of transplant. Within the 
population of patients with cancer diagnoses, this most commonly represents a stem cell transplant 
(SCT).[7] We found that children with cancer with SCT had an increased odds of admission when 
evaluated in the ED. Patients who receive a SCT are a uniquely vulnerable population of patients with 
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high rates of complications that can require emergent evaluation.[14,15] Stem cell transplant patients 
tend to be followed very closely as outpatients and remain within close proximity to the treating 
institution (for those who do not live nearby) for a period of time after discharge. Due to the 
prolonged immunocompromised status and high readmission rates of SCT patients, further analysis of 
the ED utilization of this specific population of patients may yield information that could be used to 
implement improved outpatient or phone triaging practices or provide targets for anticipatory 
guidance.  
A second unique feature of the PHIS database is the ability to identify children with cancer 
who visited the ED frequently in the year following their index admission. Frequent ED users among 
children with cancer deserve additional study to gain an understanding of the reasons for their higher 
levels of ED utilization. Our analysis determined that meeting the frequent ED user criterion was not 
associated with increased odds of admission. Further research to characterize why this population is 
seeking care in the ED could lead to targetable interventions to decrease reliance on the ED.  
 While this analysis contributes to the knowledge of ED utilization by children with cancer, it 
has also highlighted areas that deserve further evaluation. We did not have the clinical information 
that would allow us to ascertain the appropriateness of ED use by this population. The care of urgent 
medical issues among children with cancer occurs along a continuum, from outpatient triage 
regarding the need for in-person evaluation to urgent evaluation to inpatient admission. Most research 
among children with cancer to date has focused on what happens after admission,[16-18] but we 
poorly understand the events or processes that occur prior to the ED visit and admission decision. The 
decision making process for patients and their caregivers is complex and includes many facets that 
need to be better understood including decisions on when to seek care, where to seek care and who to 
contacted regarding these issues. Lastly, both patient/caregiver and provider perspectives play a role 
in triaging and decision making regarding ED use or disposition and should be addressed. All of these 
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 While this study adds insight into ED utilization by children with cancer, there are several 
important limitations. For our analysis, we captured children with cancer by identifying the first 
inpatient encounter with an associated ICD-9-CM code for cancer in the study period and then 
followed these patients for 365 days. It is possible that we are not accurately evaluating all patients 
with cancer at these institutions since a proportion of patients with cancer are diagnosed and initiated 
on therapy as outpatients. For example, many of our Hodgkin lymphoma patients are evaluated and 
diagnosed as outpatients, though this is a small population. Unfortunately, PHIS does not include 
information related to disease status, type of therapy, or time since last treatment for the patient at the 
time they visit the ED. This information should be included in prospective data collection regarding 
ED utilization in order to provide context and help to delineate associations between types of therapy 
and reasons for seeking urgent evaluation in an ED.  
Our analyses relied on discharge ICD-9-CM codes. This limits our understanding of the chief 
complaint that brought the child to seek care in the ED and therefore we are missing key information 
for future interventions aimed at anticipatory guidance. Also, we extrapolated the reason for the ED 
visit from ICD-9-CM codes rather than the initial chief complaint, which was not available in this 
dataset. For those patients who were admitted to the inpatient hospital from the ED, the diagnosis 
codes evaluated are from the entirety of the encounter and cannot be differentiated between diagnoses 
associated with the ED versus diagnoses that arose during the inpatient stay. Only a single diagnosis 
was evaluated per patient encounter, yet children with cancer may present to the ED with multiple 
complications or concerns.  
 
Admit Peds Ca  
 





In conclusion, half of children with cancer will visit the emergency department at a tertiary care 
institution within one year after the index inpatient admission for cancer. Factors that significantly 
impacted whether a child with cancer was admitted versus discharged from the ED included age, 
demographic factors and reasons for the ED visits. Knowledge of reasons for visits and patient 
characteristics may be used to target common diagnoses or design health system modifications to 
improve the care of children with cancer who visit the ED.  
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TABLE I. Encounter Level Characteristics of Children with Cancer Presenting to the Emergency Department, 








 N (% Column) N (% Row) p-value 
Patient Characteristics 
Gender 0.230 
   Female 12,491 (46.7) 5,433 (43.5) 7,058 (56.5) 
   Male 14,279 (53.3) 6,315 (44.2) 7,964 (55.8) 
Age <0.001 
    <1 year 4,306 (16.1) 2,065 (48.0) 2,241 (52.0) 
   1-4 years 7,370 (27.5) 3,400 (46.1) 3,970 (53.9) 
   5-9 years 5,979 (22.3) 2,659 (44.5) 3,320 (55.5) 
   10-14 years 5,021 (18.8) 2,045 (40.7) 2,976 (59.3) 
   15-19 years 4,094 (15.3) 1,579 (38.6) 2,515 (61.4) 
Race/Ethnicity <0.001 
    White, Non-Hispanic 14,311 (53.5) 6,299 (44) 8,012 (56) 
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   Black, Non-Hispanic 2,728 (10.2) 1,332 (48.8) 1,396 (51.2) 
   Hispanic 6,196 (23.1) 2727 (44.0) 3,469 (56.0) 
   Asian 817 (3.1) 371 (45.4) 446 (54.6) 
   Other 2,718 (10.2) 1,019 (37.5) 1,699 (62.5) 
Type of Cancer <0.001 
    Acute Lymphoblastic Leukemia  9,510 (35.5) 4,259 (44.8) 5,251 (55.2) 
   Acute Myelogenous Leukemia 1,324 (4.9) 608 (45.9) 716 (54.1) 
   Solid Tumor 8,621 (32.2) 3,601 (41.8) 5,020 (58.2) 
   Central Nervous System Tumor  4,712 (17.6) 2,212 (46.9) 2,500 (53.1) 
   Hodgkin Lymphoma 784 (2.9) 326 (41.6) 458 (58.4) 
   Non-Hodgkin Lymphoma 1,819 (6.8) 742 (40.8) 1,077 (59.2) 
Transplant <0.001 
   Yes 693 (2.6) 255 (36.8) 438 (63.2) 
   No 26,077 (97.4) 11,493 (44.1) 14,584 (55.9) 
Frequent ED User    <0.001 
   Yes 15,519 (58.0) 6,943 (44.7) 8,576 (55.3) 
   No 11,251 (42.0) 4,805 (42.7) 6,446 (57.3) 
Socioeconomic Characteristics 
Primary Payer 0.095 
   Public/ Governmental 13,308 (49.7) 5,833 (43.8) 7,475 (56.2) 
   Private 12,038 (45.0) 5,251 (43.6) 6,787 (56.4) 
   Other 1,424 (5.3) 664 (46.6) 760 (53.4) 
Median Household Income per Zip Code 0.001 
   1
st
 quartile 5,546 (21.3) 2,341 (42.2) 3,205 (57.8) 
   2
nd
 quartile 6,160 (23.7) 2,688 (43.6) 3,472 (56.4) 
   3
rd
 quartile 6,585 (25.3) 2,864 (43.5) 3,721 (56.5) 
   4
th
 quartile 7,723 (29.7) 3,528 (45.7) 4,195 (54.3) 
Urban vs Rural Patient Residence <0.001 
   Urban 23,051 (86.1) 10,354 (44.9) 12,697 (55.1) 







TABLE II.  Top Reasons Prompting ED Visits Among Pediatric Cancer Patients – Rank and 
Disposition Status by Frequent ED Visitor Status 
 
 







Rank Diagnosis N (% Column) N (% Row) 
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1 Neutropenia     5,189 (19.4)        5,061 (97.5)        128 (2.5) 
2 Fever     4,057 (15.2)         940 (23.2)      3,117 (76.8) 
3 Blood Stream Infection       883 (3.3)         667 (75.5)        216 (24.5) 
4 Nausea or vomiting       611 (2.3)         169 (27.7)        442 (72.3) 
5 Pancytopenia       557 (2.1)         537 (96.4)          20 (3.6) 
6 Acute URI       501 (1.9)        196 (39.1)        305 (60.9) 
7 Dehydration       497 (1.9)        346 (69.6)        151 (30.4) 
8 Complication of vascular device       485 (1.8)          97 (20)        388 (80) 
9 Headache       450 (1.7)          90 (20)        360 (80) 
10 Pneumonia       310 (1.2)        242 (78.1)          68 (21.9) 
URI=Upper respiratory infection 
 
 
TABLE III. Multivariate Logistic Regression to Evaluate Factors Associated with Admission Versus Discharge 
from the ED Among Pediatric Cancer Patients 
Factors        Adj. Odds Ratio (OR) 95% CI p-value 
Patient Characteristics 
Gender 
  Female 1.1 1.0-1.1 0.114 
Age 
   15-19 years Ref  
   10-14 years 0.9 0.8-1.0 0.012 
   5-9 years 0.7 0.6-0.8 <0.001 
   1-4 years 0.6 0.6-0.7 <0.001 
   <1 year 0.7 0.6-0.8 <0.001 
Race/Ethnicity    
   White, Non-Hispanic Ref   
   Black, Non-Hispanic 0.9 0.8-1.0 0.049 
   Hispanic 1.1 1.0-1.2 0.089 
   Asian 1.2 1.0-1.5 0.121 
   Other 1.4 1.2-1.6 <0.001 
Type of cancer    
   Acute Lymphoblastic Leukemia Ref   
   Acute Myelogenous Leukemia 0.9 0.8-1.1 0.304 
   Solid Tumors 0.9 0.9-1.0 0.173 
   Central Nervous System Tumor  1.1 1.0-1.2 0.221 
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   Hodgkin Lymphoma 0.7 0.6-0.9 0.005 
   Non-Hodgkin Lymphoma 0.9 0.8-1.1 0.191 
Transplant    
   Yes 1.7 1.4-2.1 <0.001 
Frequent ED Visitor    
    Yes 0.9 0.9-1.0 0.124 
Socioeconomic Characteristics 
Primary Payer 
   Public/ Governmental Ref  
   Private 0.9 0.9-1.0 0.103 
   Other 0.8 0.6-0.9 0.001 
Median Household Income per ZIP Code 
   4
th
 quartile Ref  
   3
rd
 quartile 1.1 1.0-1.2 0.017 
   2
nd
 quartile 1.1 1.0-1.2 0.267 
   1
st
 quartile 1.0 0.9-1.2 0.400 
Urban vs Rural Patient Residence    
   Urban 0.7 0.6-0.8 <0.001 
ED Visit Characteristics 
Top 10 ED Visit Diagnoses (in descending order) 
   Neutropenia 43.4 36.0-52.3 <0.001 
   Pancytopenia 28.8 18.1-45.9 <0.001 
   Pneumonia 3.8 2.8-5.1 <0.001 
   Blood Stream Infection 3.3 2.8-3.9 <0.001 
   Dehydration 2.3 1.9-2.9 <0.001 
   Acute URI 0.7 0.6-0.9 0.001 
   Nausea or vomiting 0.4 0.3-0.4 <0.001 
   Fever 0.3 0.3-0.3 <0.001 
   Complication of vascular device 0.2 0.2-0.3 <0.001 
   Headache 0.2 0.2-0.3 <0.001 
ED=Emergency Department, URI=Upper respiratory infection 
Bold indicates significant factors associated with admission versus discharge 
 
 
 
 
 
 
 
